Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
10/2014
10/07/2014US8852550 Chelator conjugates
10/07/2014US8852472 Coated lipid complexes and their use
10/02/2014WO2014161004A2 Compositions and methods for the delivery of drugs to the ocular surface by contact lenses
10/02/2014WO2014161002A2 Drug delivery from contact lenses with a fluidic module
10/02/2014WO2014160690A1 Solid forms comprising 4-amino-2-(2.6-dioxopiperidine-3-yl) isoindoline-1,3-dione and a coformer, compositions and methods of use thereof
10/02/2014WO2014160371A1 Chimeric cytokine formulations for ocular delivery
10/02/2014WO2014160360A1 Tubulysin compounds and conjugates thereof
10/02/2014WO2014160305A1 Ligand-therapeutic agent conjugates and silicon-based linkers
10/02/2014WO2014160279A1 Stabilized cream formulations comprising sandalwood oil
10/02/2014WO2014160187A1 Cardiovascular disease treatment and prevention
10/02/2014WO2014160167A1 Implantable drug delivery compositions comprising aromatic polyurethanes and methods of treatment thereof
10/02/2014WO2014160160A2 Antibody drug conjugates
10/02/2014WO2014160102A1 Brain and neural treatments comprising peptides and other compositions
10/02/2014WO2014160069A1 Compositions and methods for affecting mood states
10/02/2014WO2014160049A1 Topical systems and methods for treating sexual dysfunction
10/02/2014WO2014160015A1 Skin tanning using peptides and other compositions
10/02/2014WO2014159987A1 Hair treatment systems and methods using peptides and other compositions
10/02/2014WO2014159917A2 Treatment for exposure to nerve agent
10/02/2014WO2014159835A1 Anti-b7-h4 antibodies and immunoconjugates
10/02/2014WO2014159759A1 Compositions and associated methods for radioisotope-binding microparticles
10/02/2014WO2014159171A1 Methods of treating lung cancer
10/02/2014WO2014159051A1 Stable bioactive substances and methods of making
10/02/2014WO2014158965A1 Method and reagent for preparing a diagnostic composition
10/02/2014WO2014158963A1 Antibodies targeted to fungal cell wall polysaccharides
10/02/2014WO2014158554A1 Process for making hmf from sugars with reduced byproduct formation, and improved stability hmf compositions
10/02/2014WO2014158001A1 Composition comprising at least two influenza a virus-neutralizing-binding molecules
10/02/2014WO2014157989A1 Stabilized composition containing voriconazole
10/02/2014WO2014157852A1 Sustained-release medicinal composition containing eperisone as active ingredient
10/02/2014WO2014157851A1 Eperisone pharmaceutical composition having improved preservability and ph stability
10/02/2014WO2014157603A1 Pharmaceutical composition for oral administration
10/02/2014WO2014157484A1 Tablet for preparing solution of chlorine dioxide
10/02/2014WO2014157436A1 Pharmaceutical composition for external application
10/02/2014WO2014157264A1 Film-coated orally disintegrating tablet
10/02/2014WO2014157150A1 Hydrophilic polymer derivative having benzylidene acetal linker
10/02/2014WO2014157137A1 Oral administration preparation with masked bitterness of silodosin
10/02/2014WO2014156958A1 Nano-capsule, composition, polynucleotide, recombinant vector, and transformant
10/02/2014WO2014156505A1 Jelly-like tablet and jelly-like lozenge using same
10/02/2014WO2014155146A1 Stable nanocomposition comprising paclitaxel, process for the preparation thereof, its use and pharmaceutical compositions containing it
10/02/2014WO2014155145A1 Stable nanocomposition comprising epirubicin, process for the preparation thereof, its use and pharmaceutical compositions containing it
10/02/2014WO2014155144A1 Stable nanocomposition comprising docetaxel, process for the preparation thereof, its use and pharmaceutical compositions containing it
10/02/2014WO2014155142A1 Stable nanocomposition comprising doxorubicin, process for the preparation thereof, its use and pharmaceutical compositions containing it
10/02/2014WO2014155103A1 Taurine compositions suitable for inhalation
10/02/2014WO2014154804A1 Pharmaceutical formulation for use in the treatment and/or prevention of restenosis
10/02/2014WO2014154029A1 Composite structural material and pharmaceutical composition thereof
10/02/2014US20140296641 COMPOSITIONS, FORMULATIONS AND METHODS OF BIO-BALANCING THE pH OF STERILE HYPOTONIC, ISOTONIC SALINE AND HYPERTONIC SALINE SOLUTIONS
10/02/2014US20140296509 Polyol and Polyether Iron Oxide Complexes as Pharmacological and/or MRI Contrast Agents
10/02/2014US20140296476 Prodrugs and drug-macromolecule conjugates having controlled drug release rates
10/02/2014US20140296451 Chelating complex micelles drug carrier
10/02/2014US20140296435 Pharmaceutical composition of chelating complex micelles
10/02/2014US20140296354 Synthesis of peptoid-based small molecular gelators from multiple component reactions
10/02/2014US20140296353 Prion free nanoparticle compositions and methods of making thereof
10/02/2014US20140296351 Pharmaceutical formulation
10/02/2014US20140296348 Ophthalmological aqueous composition
10/02/2014US20140296342 Pharmaceutical Formulation Comprising NSAID And Cyclodextrin
10/02/2014US20140296336 Solid retard formulations based on solid dispersions
10/02/2014US20140296334 N-Optionally Substituted Aryl-2-Oligomer-3-Alkoxypropionamides
10/02/2014US20140296328 High concentration olopatadine ophthalmic composition
10/02/2014US20140296309 Modified release compositions of epalrestat or a derivative thereof and methods for using the same
10/02/2014US20140296301 Topical ophthalmological pharmaceutical composition containing regoragenib
10/02/2014US20140296299 Methods and compositions for locally increasing body fat
10/02/2014US20140296282 Compositions of a polyorthoester and an aprotic solvent
10/02/2014US20140296279 Intravascular delivery of nanoparticle compositions and uses thereof
10/02/2014US20140296277 Pharmaceutical preparation containing oxycodone and naloxone
10/02/2014US20140296267 Solid dispersions of a erb2 (her2) inhibitor
10/02/2014US20140296257 High-Loading Water-Soluable Carrier-Linked Prodrugs
10/02/2014US20140296191 Compositions of pharmaceutical actives containing diethylene glycol monoethyl ether or other alkyl derivatives
10/02/2014US20140296174 Silk-based multifunctional biomedical platform
10/02/2014US20140296173 Stable nanocomposition comprising epirubicin, process for the preparation thereof, its use and pharmaceutical compositions containing it
10/02/2014US20140296158 Sustained action formulation of cyclosporin form 2
10/02/2014US20140296150 Carrier-Linked Treprostinil Prodrugs
10/02/2014US20140296145 Modified Human Growth Hormone Polypeptides and Their Uses
10/02/2014US20140295521 Method for reducing the immune response to a biologically active protein
10/02/2014US20140294981 Carbon encapsulated transition metal oxide nanocomposite, a method for its preparation and its use in li-ion batteries
10/02/2014US20140294978 Cationic lipid
10/02/2014US20140294974 Cosmetic composition
10/02/2014US20140294970 Stabilized pharmaceutical sub-micron suspensions and methods of forming same
10/02/2014US20140294969 Method and formulation for inhalation
10/02/2014US20140294967 Stable nanocomposition comprising paclitaxel, process for the preparation thereof, its use and pharmaceutical compositions containing it
10/02/2014US20140294966 Stable nanocomposition comprising docetaxel, process for the preparation thereof, its use and pharmaceutical compositions containing it
10/02/2014US20140294950 Methods of treating obesity in responder and non-responder populations
10/02/2014US20140294948 Composition as auxiliary means for oral medication
10/02/2014US20140294944 Microencapsulation of oxygen liberating reactants
10/02/2014US20140294937 Lipid compositions for nucleic acid delivery
10/02/2014US20140294935 Vaccine composition
10/02/2014US20140294934 Cationic lipids for therapeutic agent delivery formulations
10/02/2014US20140294933 Composition for delivery of angiogenesis inducing molecule and artificial tissue prepared by the composition
10/02/2014US20140294931 Method and composition of thyroid hormone analogues and nanoformulations thereof for treating anti-inflammatory disorders
10/02/2014US20140294929 Compositions for delivery of cargo such as drugs proteins and/or genetic materials
10/02/2014US20140294926 Treatment for exposure to nerve agent
10/02/2014US20140294919 Vaccines
10/02/2014US20140294917 Thermoset and thermoplastic fibers and preparation thereof by uv curing
10/02/2014US20140294909 Nanocomposites of gold and polymers
10/02/2014US20140294902 Novel a4b7 peptide antagonists
10/02/2014US20140294887 Adjuvanting meningococcal factor h binding protein
10/02/2014US20140294877 Disulfide-linked polyethyleneglycol/peptide conjugates for the transfection of nucleic acids
10/02/2014US20140294868 Pyrrolobenzodiazepines and conjugates thereof
10/02/2014US20140294867 Site-specific antibody-drug conjugation through glycoengineering
10/02/2014US20140294865 Amatoxin-conjugates with improved linkages
10/02/2014US20140294864 Drug conjugate composition
10/02/2014US20140294863 Serum albumin binding peptides for tumor targeting
1 ... 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 ... 1712